Jane Street Group LLC Increases Stock Holdings in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX)
Jane Street Group LLC lifted its position in Lineage Cell Therapeutics, Inc. (NYSEAMERICAN:LCTX – Free Report) by 119.2% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 262,866 shares of the company’s stock after purchasing an additional 142,965 shares during the period. Jane Street Group LLC’s holdings in Lineage Cell Therapeutics were worth $132,000 […]
